Paid Clinical Trials Cedar Rapids

Discover 519 paid clinical trials in Cedar Rapids, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 519

PF-08046054A Study of SGN-PDL1V in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Seagen Inc.

Location:

Iowa City IA, Farmington Hills MI, Detroit MI, Cleveland OHshow 8 more

Code:

NCT05208762

Conditions

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of the Head and Neck

Esophageal Squamous Cell Carcinoma

Ovarian Neoplasms

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08046054

pembrolizumab

MRI AssessmentQuantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting

Sponsor:

OHSU Knight Cancer Institute

Location:

Iowa City IA, Seattle WA, Portland OR

Code:

NCT05704062

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Diffusion Weighted Imaging

Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Observational StudyLGMD R1 Natural History Study

Recruiting

Sponsor:

Virginia Commonwealth University

Location:

Iowa City IA, Minneapolis MN, Saint Louis MO, Kansas City KSshow 6 more

Code:

NCT05618080

Conditions

Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A

Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy Type R1

LGMD2A

Eligibility Criteria

Sex: All

Age: 12 - 50

Healthy Volunteers: Not accepted

Crenolanib vs. MidostaurinStudy of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

PHASE3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Iowa City IA, Chicago IL, Minneapolis MN, Kansas City KSshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

Single vs. MultipleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Recruiting

Sponsor:

Weill Medical College of Cornell University

Location:

Iowa City IA, Chicago IL, Omaha NE, Saint Louis MOshow 45 more

Code:

NCT04124120

Conditions

Heart Diseases

Coronary Artery Disease

Coronary Artery Bypass Grafting

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single arterial graft

Multiple arterial grafting

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Iowa City IA, Rochester MN, Chicago IL, Hammond INshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

IbrutinibA Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

Recruiting

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Iowa City IA, Springfield IL, Hinsdale IL, Minneapolis MNshow 29 more

Code:

NCT05963074

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ibrutinib

Venetoclax

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Cedar Rapids IA, Iowa City IA, Marshalltown IA, Bettendorf IAshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Lenalidomide & DaratumumabS1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Recruiting

PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Cedar Rapids IA, Iowa City IA, Marshalltown IA, Bettendorf IAshow 530 more

Code:

NCT04071457

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Lenalidomide

Daratumumab/rHuPH20

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Iowa City IA, Des Moines IA, Madison WI, Rochester MNshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate